Synklino
20+ years of experience in the pharmaceutical industry. Executive managerial positions in international pharmaceutical and biotech companies Ablynx, GPC-Biotech, Gilead Sciences, Bristol-Myers Squibb and LEO Pharma.
This person is not in any offices
Synklino
1 followers
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.